Rate My Professor Pradeep Tanwar

Professor Pradeep Tanwar is a prominent researcher in the field of gynaecological diseases formerly at the University of Newcastle, Australia. He served as Founding Director of the Global Centre for Gynaecological Diseases and was based in the School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing. Tanwar's academic background includes a Bachelor of Veterinary Science from Lala Lajpat Rai University of Veterinary and Animal Sciences (1997-2002), a PhD in reproductive tract biology from the University of New England (2004-2007), and postdoctoral training in Obstetrics and Gynecology Oncology at Harvard Medical School (2007-2012). After joining the University of Newcastle, he progressed to tenured Professor and held key fellowships such as NHMRC Career Development Fellow, ARC Future Fellow, and Cancer Institute NSW Career Development Fellow. In 2022, he received the HMRI Mid-Career Researcher of the Year award. His research has accumulated over 4,200 citations with publications in leading journals.

Tanwar's research focuses on the pathogenesis of gynaecological cancers, including ovarian and endometrial cancers. Notable contributions include elucidating adipose-derived VEGF-mTOR signaling's role in obesity-associated endometrial cancer (Oncoscience, 2018), developing hydrogels from bovine and human endometrium to support endometrial organoid growth (PNAS, 2022), and proteomic characterization of intra-tumor heterogeneity in high-grade serous ovarian cancer (Cell Reports Medicine, 2022). He identified Axin2+ endometrial stem cells responsible for epithelial regeneration (Cell Stem Cell, 2020) and advanced understanding of Wnt/β-catenin signaling in uterine stroma leading to mesenchymal tumors (Biology of Reproduction, 2009). Additional work covers extracellular matrix in serous ovarian cancer, organoid models for fallopian tube and uterus, and protective mechanisms of contraceptive pills against ovarian cancer. Tanwar secured major grants, including NHMRC and ARC funding for ovarian cancer research (2021), and contributed to techniques like organ culture and immunofluorescence staining of reproductive tracts. His findings have influenced gynaecological cancer biology and regenerative medicine.